Pharma export milestone: SINOQUAL's dual certification powers Jiangsu Weiqida into new global markets

In today's increasingly competitive global landscape, product certification has become an important passport for enterprises going global. SINOQUAL recently helped Jiangsu Weqida Pharmaceutical Co., Ltd. pass both HFC Halal certification and BDZ Kosher certification in one go, laying a solid foundation for its products to enter the Islamic and kosher markets.

A subsidiary of Shanghai Modern Pharmaceutical Co., Ltd., Jiangsu Weqida Pharmaceutical possesses strong R&D capabilities, a professional talent team and advanced equipment, focusing on high-tech, high-value-added, low-emission specialty APIs. It aims to become a comprehensive pharmaceutical enterprise integrating chemical API production, intermediate R&D, pilot testing and custom processing, and the R&D and production of health products. Its main products cover anti-infectives, cardiovascular and health categories, reaching more than 20 countries and regions. As its overseas strategy advanced, Weqida urgently needed a platform that could provide one-stop internationally recognized Halal and Kosher certification to help it obtain the key to broader markets in the Middle East, Southeast Asia and North America.

Dual certification unlocks the passport to global markets

HFC Halal certification: As a core bridge between religious belief and food safety, Halal certification is a rigid market-entry requirement in the Middle East, Southeast Asia and beyond, and its strict production standards also win favor among non-Muslim consumers. This certification allowed Weqida's pharmaceutical products to enter international markets with strict Halal requirements, opening up billions in incremental space.

BDZ Kosher certification: A globally accepted certification from an Israeli Orthodox Jewish body, sharing the same standard system as international giants such as Unilever and Coca-Cola, it is a golden key to high-end Western Jewish markets. Leveraging its deep cooperation with the BDZ certification team, SINOQUAL ensured Weqida complied with Orthodox kosher norms across the full chain from raw-material procurement to production, earning strong recognition from Jewish customers worldwide.

Professional empowerment to solve certification challenges

Pharmaceutical certification is complex and demanding. SINOQUAL helped Weqida obtain certification efficiently through three core strengths:

Direct authoritative authorization: With direct authorization from both HFC and BDZ, SINOQUAL helps companies skip cumbersome intermediaries and deal directly with the bodies, multiplying communication and certification efficiency.

Full-process customized service: The professional team goes deep into the production line, from document translation and document-review coaching to on-site audit rectification, helping companies build Halal and kosher production management systems, refine traceability documents, and providing end-to-end accompaniment.

Deep pharmaceutical experience: Having served several pharmaceutical companies such as Sinopharm and NHU, SINOQUAL precisely matches the special compliance requirements of pharmaceutical products.

The successful dual certification not only makes Jiangsu Weqida's products fit diverse global cultural demands but also breaks through international trade barriers, enhancing brand credibility with the dual endorsement of compliance and quality, seizing the lead in the Halal and kosher pharmaceutical segments, and upgrading the company from product export to brand export. It is also more than a breakthrough in product qualifications; it is an important practice of Chinese pharmaceutical companies proactively adapting to international standards and deeply participating in the global value chain. Through professional certification service, SINOQUAL will fully help enterprises turn cultural differences into market opportunities and win broader international trust for Chinese manufacturing.